Evaluation of Tranexamic Acid in reducing blood loss during planned Caesarean birth
Not Applicable
- Conditions
- Health Condition 1: Z332- Encounter for elective terminationof pregnancy
- Registration Number
- CTRI/2022/04/041835
- Lead Sponsor
- Esaivaani V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Full term primigravida or multigravida with singleton pregnancy delivered by elective lower segment caesarean section
Exclusion Criteria
1) Intake of anti-platelet agents, 2) History of thrombo-embolic disorder, 3) Pregnancy complications such as severe pre-eclampsia, abruptio placenta, placenta previa, fibroid complicating pregnancy, 4) Any blood dyscrasias, 5) Allergy to tranexamic acid, 6) Multiple pregnancy, 7) Polyhydramnios
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood loss during caesarean sectionTimepoint: At the end of caesarean section
- Secondary Outcome Measures
Name Time Method Percentage difference in hemoglobin before and after LSCSTimepoint: 1 year